AF
ORKA

Allworth Financial’s Oruka Therapeutics ORKA Stock Holding History

Allworth Financial’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.7K Sell
186
-19
-9% -$1.27K ﹤0.01% 3303
2026
Q1 		$10.1K Buy
205
+91
+80% +$3.16K ﹤0.01% 3501
2025
Q4 		$3.46K Buy
114
+109
+2,180% +$3.04K ﹤0.01% 3910
2025
Q3 		$97 Hold
5
– – ﹤0.01% 4684
2025
Q2 		$57 Buy
+5
New +$52 ﹤0.01% 4442

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Allworth Financial's ORKA Position: Q2 2026 in Review

Allworth Financial reduced its Oruka Therapeutics (ORKA) stake by 9.3% in Q2 2026, selling an estimated $1.27K and leaving 186 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3303.

Allworth Financial first reported a position in ORKA in Q2 2025 and has held it in 5 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Allworth Financial held 186 shares of Oruka Therapeutics worth $17.7K as of Q2 2026.
  • Allworth Financial sold 19 Oruka Therapeutics shares in Q2 2026, an estimated $1.27K.
  • Oruka Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3303 holding.
  • Allworth Financial first reported a position in Oruka Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.